Impact of prostatic anterior fat pads with lymph node staging in prostate cancer
Wei‐Chun Weng(Mackay Junior College of Medicine, Nursing and Management), Shun‐Fa Yang(Chung Shan Medical University Hospital), Yen‐Chuan Ou(Tungs' Taichung MetroHarbor Hospital), Cheng‐Kuang Yang(Taichung Veterans General Hospital), Min‐Che Tung(National Chung Hsing University), Chao‐Yu Hsu(National Chung Hsing University), Jong‐Shiaw Jin(Tungs' Taichung MetroHarbor Hospital), Li‐Hua Huang(Zhujiang Hospital)
Cited by 6
Related Papers
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Oncology|2020|502
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
|European Urology|2006|176
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
|European Urology|2010|154
Oral microbial dysbiosis and its performance in predicting oral cancer
|Carcinogenesis|2020|143